Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Geovax Labs Inc (NASDAQ:GOVX), Genprex Inc (NASDAQ:GNPX), AquaBounty Technologies Inc (NASDAQ:AQB) and Indaptus Therapeutics Inc (NASDAQ:INDP).
Moleculin Biotech has a consensus price target of $13.83.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $2.07 last updated March 20, 2026 at 7:49 PM EDT.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.